Isoflurane Preconditioning Delays Opening of Mitochondrial Permeability Transition Pore via Protein Kinase C Signaling Pathway

Abstract

Isoflurane protects the myocardium from ischemia and reperfusion (I/R) injury via protein kinase C (PKC) signaling pathway. It has been suggested that the mitochondrial permeability transition pore (mPTP) is the end effector of I/R injury, whereas PKC has a protective effect by blocking mPTP opening. Here we investigated whether anesthetic preconditioning (APC) with isoflurane delays mPTP opening and whether the PKC plays a role in isoflurane‐induced delay in mPTP opening. Isoflurane preconditioned rat cardiomyocytes were loaded with fluorescent probe tetramethylrhodamine ethyl ester (TMRE) and subjected to a simulated I/R injury by laser‐induced ROS production. Using the laser‐scanning confocal microscopy, we measured the time to 50% decrease in TMRE fluorescence, which coincides with depolarization of the mitochondria and represents an opening of mPTP. To confirm the role of mPTP, we used cyclosporine A (CsA). The role of PKC was tested using the non‐specific PKC inhibitor chelerythrine (CHEL). APC with isoflurane prolonged the mean depolarization time of the control fluorescence of 216±8 s, to 261±16 s. A similar time delay of 279±22 s was found in cells pretreated with CsA. Isoflurane‐induced delay in an mPTP opening was abrogated to 219±7 s in cells treated with CHEL. In conclusion, our results indicate that APC with isoflurane delays the opening of mPTP in a PKC‐dependent manner.Supported by NIH (HL 034708 and GM 066730)